| Fibroblast growth factor-2 MA Nugent, RV Iozzo The international journal of biochemistry & cell biology 32 (2), 115-120, 2000 | 672 | 2000 |
| Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. ER Edelman, MA Nugent, MJ Karnovsky Proceedings of the National Academy of Sciences 90 (4), 1513-1517, 1993 | 342 | 1993 |
| Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure A Nehra, I Goldstein, A Pabby, M Nugent, YH Huang, A de las Morenas, ... The Journal of urology 156 (4), 1320-1329, 1996 | 332 | 1996 |
| Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. ER Edelman, MA Nugent, LT Smith, MJ Karnovsky The Journal of clinical investigation 89 (2), 465-473, 1992 | 330 | 1992 |
| Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperativity MA Nugent, ER Edelman Biochemistry 31 (37), 8876-8883, 1992 | 304 | 1992 |
| Sustained down-regulation of the epidermal growth factor receptor by decorin: a mechanism for controlling tumor growth in vivo G Csordas, M Santra, CC Reed, I Eichstetter, DJ McQuillan, D Gross, ... Journal of Biological Chemistry 275 (42), 32879-32887, 2000 | 280 | 2000 |
| Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. B Sharma, M Handler, I Eichstetter, JM Whitelock, MA Nugent, RV Iozzo The Journal of clinical investigation 102 (8), 1599-1608, 1998 | 253 | 1998 |
| Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding CJ Dowd, CL Cooney, MA Nugent Journal of Biological Chemistry 274 (8), 5236-5244, 1999 | 239 | 1999 |
| Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response M Fannon, KE Forsten, MA Nugent Biochemistry 39 (6), 1434-1445, 2000 | 211 | 2000 |
| Heparinase inhibits neovascularization. R Sasisekharan, MA Moses, MA Nugent, CL Cooney, R Langer Proceedings of the National Academy of Sciences 91 (4), 1524-1528, 1994 | 178 | 1994 |
| Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia MA Nugent, HM Nugent, RV Iozzo, K Sanchack, ER Edelman Proceedings of the National Academy of Sciences 97 (12), 6722-6727, 2000 | 158 | 2000 |
| Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate M Fannon, MA Nugent Journal of Biological Chemistry 271 (30), 17949-17956, 1996 | 144 | 1996 |
| Heparan sulfate–FGF10 interactions during lung morphogenesis KI Izvolsky, D Shoykhet, Y Yang, Q Yu, MA Nugent, WV Cardoso Developmental biology 258 (1), 185-200, 2003 | 141 | 2003 |
| pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release AL Goerges, MA Nugent Journal of Biological Chemistry 279 (3), 2307-2315, 2004 | 133 | 2004 |
| Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal–regulated kinases 1 and 2 CC Chua, N Rahimi, K Forsten-Williams, MA Nugent Circulation research 94 (3), 316-323, 2004 | 131 | 2004 |
| Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells GV Sperinde, MA Nugent Biochemistry 37 (38), 13153-13164, 1998 | 124 | 1998 |
| Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites M Mitsi, Z Hong, CE Costello, MA Nugent Biochemistry 45 (34), 10319-10328, 2006 | 122 | 2006 |
| Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling E Hsia, TP Richardson, MA Nugent Journal of cellular biochemistry 88 (6), 1214-1225, 2003 | 114 | 2003 |
| Tissue engineered perivascular endothelial cell implants regulate vascular injury. A Nathan, MA Nugent, ER Edelman Proceedings of the National Academy of Sciences 92 (18), 8130-8134, 1995 | 112 | 1995 |
| Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. MA Nugent, MJ Karnovsky, ER Edelman Circulation research 73 (6), 1051-1060, 1993 | 111 | 1993 |
Elazer R. EdelmanProfessor of Health Sciences and Technology, MITVerified email at mit.edu
